Introduction The pace of biomarker discovery has increased exponentially over the last few
years, ushering in an era of precision medicine (PM) with a growing arsenal of treatments …

Evidence of the value of pharmacogenomic testing is needed to inform policymakers and
clinicians for decision making related to adoption and coverage, and to facilitate …

Background Precision oncology medicines represent a paradigm shift compared to non-
precision oncology medicines in cancer therapy, in some situations delivering more clinical …

Aim: The ICPerMed, international initiative promoting personalized medicine, has realized a
survey among a group of experts, to define a common vision for the deployment of …

To overcome the problems of long production cycle and high cost in the product
manufacturing process, a P2P (platform to platform) cloud manufacturing method based on a …

The concept of MyData emerged as a paradigm shift in personal data management and the
process of seeking to transform the current organization-centered system. MyData enables …

Rising pressure from chronic diseases means that we need to learn how to deal with
challenges at a different level, including the use of systems approaches that better connect …

The development of genomic technologies has ushered in the era of pharmacogenomics.
However, discoveries and clinical use of targeted therapies are still in their infancy. A focus …

Introduction: Even if cardiovascular disease (CVD) drugs are supported by high level proofs,
the results of CVD treatment present great disparities: there are still patients dying with …

Abstract Rationale Stratified Medicine (SM) is becoming a natural result of advances in
biomedical science and a promising path for the innovation-based biopharmaceutical …